{
    "organizations": [],
    "uuid": "511bee40e5a9e7522194c053ad3a9917718eee32",
    "author": "",
    "url": "https://www.reuters.com/article/brief-synlogic-receives-fast-track-desig/brief-synlogic-receives-fast-track-designation-for-synb1618-a-synthetic-biotic-medicine-for-treatment-of-phenylketonuria-idUSFWN1S20LP",
    "ord_in_thread": 0,
    "title": "BRIEF-Synlogic Receives Fast-Track Designation For Synb1618, A Synthetic Biotic Medicine For Treatment Of Phenylketonuria",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 25 (Reuters) - Synlogic Inc:\n* SYNLOGIC RECEIVES FAST-TRACK DESIGNATION FOR SYNB1618, A SYNTHETIC BIOTICâ„¢ MEDICINE FOR THE TREATMENT OF PHENYLKETONURIA\n* SYNLOGIC INC - PHASE 1/2A CLINICAL STUDY OF SYNB1618 EXPECTED TO REPORT INTERIM DATA IN 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T14:16:00.000+03:00",
    "crawled": "2018-04-25T14:30:46.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "synlogic",
        "inc",
        "synlogic",
        "receives",
        "designation",
        "synb1618",
        "synthetic",
        "medicine",
        "treatment",
        "phenylketonuria",
        "synlogic",
        "inc",
        "phase",
        "clinical",
        "study",
        "synb1618",
        "expected",
        "report",
        "interim",
        "data",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}